Study to Evaluate the Efficacy and Safety of DA-1241 in Subjects With Presumed NASH
Clinical trial NCT06054815 · COMPLETED
Trial details
- NCT number
- NCT06054815
- Sponsor
- NeuroBo Pharmaceuticals Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-09-14
- Primary completion
- 2024-10-24
- Enrollment
- 109
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.